Instalab
logoInstalab

FFRCT - LCX (Distal)

Help clarify whether plaque in the artery supplying the side and back of your heart restricts blood flow.

Should you take a FFRCT - LCX (Distal) test?

This test is most useful if any of these apply to you.

Holding a Heart CT Report
Understand how the far-end circumflex value fits with plaque, vessel shape, and readings around any narrowing.
Getting Chest Discomfort With Exertion
If CT shows an intermediate narrowing, flow modeling may help clarify whether it restricts the heart's blood supply.
Considering a Procedure for a Narrowing
Use the full pressure map and CT findings to inform a cardiologist's assessment of whether further testing or a procedure could help.
Seeing a Low Reading Despite Little Plaque
Understand why a terminal value can be low and why it needs to be interpreted with the rest of the scan.

About FFRCT - LCX (Distal)

If a heart CT finds plaque in the left circumflex artery, the next question is whether it restricts blood flow to the heart muscle. FFRCT helps answer that question by estimating pressure along the artery. The distal result comes from its far end, where the effects of upstream narrowings, diffuse plaque, and vessel shape have accumulated.

FFRCT is an established tool for evaluating intermediate coronary narrowings, especially when you have stable chest symptoms. The evidence for using an isolated far-end circumflex value to make treatment decisions is less developed. It belongs with the CT images and the pressure readings around any narrowing.

How the Calculation Works

FFRCT stands for fractional flow reserve derived from coronary CT angiography. It estimates the ratio of pressure inside a coronary artery to pressure in the aorta during simulated maximum blood flow. The aorta carries blood out of the heart. Lower ratios represent greater estimated pressure loss.

Software builds a three-dimensional model of the coronary arteries from the CT images. The standard HeartFlow FFRCT analysis uses physics-based blood-flow modeling to estimate the pressure along those vessels. This is an imaging-derived result; it doesn't measure a substance in blood or directly measure the volume of blood reaching the muscle.

The left circumflex artery branches from the left main coronary artery and curves around the side and back of the heart. Its distal reading includes pressure losses along the modeled path. A focal narrowing can produce a sharp drop, while diffuse disease or vessel geometry can produce a gradual decline. The distal number alone cannot locate the source of that loss.

A lesion-specific reading is taken a short distance downstream from a particular narrowing. Comparing it with the reading before that narrowing helps assess its contribution. This distinction matters because the far-end value can be low even when no single narrowing restricts flow enough to warrant a procedure.

Why Arteries Can Give Different Results

The circumflex generally has higher FFRCT readings than the left anterior descending artery, which runs down the front of the heart. That pattern appeared in the ADVANCE registry of more than 5,000 people with suspected coronary disease. Those clinical measurements weren't a reference range for a fixed point at the end of the circumflex. Vessel length, branching pattern, and the amount of muscle supplied all affect the pressure profile.

Heart Attack and Cardiac Death Risk

Lower FFRCT values are associated with more heart attacks and cardiovascular deaths in people evaluated for coronary disease. Most outcome studies combine information from several arteries and use either readings below a narrowing or the lowest distal value. Their risk estimates don't apply directly to your distal circumflex number in isolation.

A nationwide English study followed 7,836 people for about three years. Markedly reduced readings below a narrowing were associated with about three times the heart attack risk after accounting for clinical risk factors and the degree of narrowing on CT. The lowest category also had about three times the risk of cardiovascular death. Among people whose lesion-specific readings were reassuring, about 1.5% had a heart attack or cardiovascular death over three years. Distal readings also predicted events, although lesion-specific readings provided somewhat better information for predicting heart attacks.

A meta-analysis of 22 studies found that abnormal CT-derived pressure ratios were associated with roughly four times the risk of major cardiovascular events and roughly three times the risk of death or heart attack. The studies used different software, measurement locations, and outcome definitions. Some combined outcomes included procedures that the test result itself could influence, and evidence of publication bias made the size of the association less certain.

These studies support FFRCT as one part of risk assessment. They don't establish that raising a distal circumflex value prevents a heart attack, or that a low value by itself identifies an artery that needs a stent. Plaque can remain clinically relevant even when it doesn't restrict flow.

Low Readings Without a Focal Blockage

A study of male marathon runners illustrates the problem. Of 98 enrolled runners, 59 without coronary narrowing were evaluated with an investigational on-site CT-FFR prototype. About 37% had at least one distal reading classified as abnormal, including five with a low distal circumflex reading. This was different software from standard HeartFlow FFRCT, and there was no invasive pressure-wire comparison. The finding supports caution about terminal readings; it doesn't establish this test's false-positive rate.

In a separate study using HeartFlow in arteries without apparent coronary disease, longer vessels and wider branching angles were associated with lower distal readings. Diffuse plaque can also cause a gradual pressure decline without forming one tight blockage. These are possible explanations for a low value, so a scan without a focal narrowing requires interpretation of the full vessel and image quality before the number is attributed to disease.

When Results Can Be Misleading

Measurement location changes interpretation. In one study, about 44% of people classified as abnormal using the lowest vessel value were reclassified as negative when the reading just downstream from a narrowing was used instead. That was a change in classification, not proof that every reclassified person had healthy arteries.

A study with invasive pressure-wire measurements as the reference found that readings taken 1 to 2 cm beyond a narrowing correctly classified more vessels without flow-limiting disease than far-end readings did. This study included several coronary arteries and did not separately validate the distal circumflex result.

  • Heavy calcium: dense calcium can obscure the artery's inner boundary on CT. In a study of people with extensive calcification, using the lowest vessel value produced many false-positive results.
  • Motion and image quality: a fast or irregular heartbeat can blur the artery. Motion was the leading reason scans were rejected for analysis in a large study. Inaccurate reconstruction of the vessel can also distort a completed calculation.
  • Incomplete artery widening: nitroglycerin helps widen the coronary arteries before imaging. Inadequate widening can make the modeled vessel appear narrower and lower its estimated pressure ratio.
  • Small terminal branches: tiny or poorly defined segments are difficult to reconstruct accurately. A low value confined to the very end needs particular caution.
  • Different measurement locations or software: a distal value, a value below a narrowing, and a result from another CT-FFR algorithm are different measurements. Their numbers aren't interchangeable.

A small study of independent analyses of the same CT images reported about 3% relative variability. That result doesn't establish how much change between separate scans is meaningful. A new scan also introduces differences in image quality, vessel widening, and the exact point being compared. Women had higher FFRCT values than men at comparable degrees of narrowing in the ADVANCE registry, another reason to interpret the number in context.

What Serial Scans Have Shown

In an observational study of 71 adults scanned about five years apart, distal readings improved in about 28% of vessels, remained stable in about 45%, and worsened in about 27%. Improvement was associated with less high-risk plaque and a wider vessel opening. Higher total cholesterol and increasing narrowing were associated with worsening readings.

The study combined several coronary arteries and used study-specific definitions of change. It supports investigating distal FFRCT as a way to follow coronary disease, but it doesn't establish a circumflex-specific treatment target or show that scheduled repeat scans improve health outcomes.

What Moves This Biomarker

Evidence-backed interventions that affect your FFRCT - LCX (Distal) level

↑ Increase
Coronary stenting of a focal, flow-limiting narrowing
Opening a focal narrowing can raise the downstream pressure ratio by reducing the pressure lost across it. A CT-based planning study in 120 people compared predicted post-stent values with invasive pressure-wire measurements after treatment. This supports the physiological effect and virtual planning, but was not a study of repeat distal circumflex FFRCT after stenting. The benefit varies with how much pressure loss comes from the treated narrowing; diffuse disease can leave residual pressure loss.
ProcedureStrong Evidence
↑ Increase
Prescription icosapent ethyl, 4 grams daily, added to statin treatment
Distal FFRCT declined less with icosapent ethyl than with placebo over 18 months: the average change was -0.01 versus -0.09. This was a 47-person imaging substudy of a randomized trial, using the most diseased coronary vessel for each person. It supports preservation of the estimated pressure ratio, but did not establish a distal circumflex-specific benefit.
MedicationModest Evidence

Frequently Asked Questions

References

26 studies
  1. Jonathan R. Weir-mccall, Lynne Koweek, Dominika Suchá, Bjarne Linde Nørgaard, Nick Curzen, Timothy a. Fairbairn, Lauren a. Baldassarre, Rhanderson Cardoso, Kavitha Chinnaiyan, Martin Hadamitzky, Julia Karady, Joo Myung Lee, Pal Maurovich-horvat, Edward D. Nicol, Koen Nieman, Gianluca Pontone, Prabhakar Rajiah, U. Joseph Schoepf, Arnold H. Seto, Ronak RajaniJournal of Cardiovascular Computed Tomography2026
  2. Sebastian Gassenmaier, Ilias Tsiflikas, Simon Greulich, Jens Kübler, Florian Hagen, Konstantin Nikolaou, Andreas Michael Niess, Christof Burgstahler, Patrick KrummEuropean Radiology2021
  3. Toshimitsu Tsugu, Kaoru Tanaka, Yuji Nagatomo, Dries Belsack, Hannes Devos, Nico Buls, Bernard Cosyns, Jean‐françois Argacha, Michel Octave De Maeseneer, Johan De MeyEuropean Radiology2022
  4. Timothy a. Fairbairn, Koen Nieman, Takashi Akasaka, Bjarne Linde Nørgaard, Daniel S. Berman, Gilbert L Raff, Lynne Koweek, Gianluca Pontone, Tomohiro Kawasaki, Niels Peter Rønnow Sand, Jesper Møller Jensen, Tetsuya Amano, Michael Poon, Kristian Altern ØVrehus, Jeroen Sonck, Mark Rabbat, Sarah Mullen, Bernard De Bruyne, Campbell Rogers, Hitoshi Matsuo, Jeroen Joost Bax, Jonathon a Leipsic, Manesh R. PatelEuropean Heart Journal2018
  5. Hans Mickley, Karsten Tange Veien, Oke Gerke, Jess Lambrechtsen, Allan Rohold, Flemming Hald Steffensen, Mirza Husic, Dilek Akkan, Martin Busk, Louise Brügmann Jessen, Lisette Okkels Jensen, Axel Cosmus Pyndt Diederichsen, Kristian Altern ØVrehusJACC. Cardiovascular Imaging2022